Medical marijuana production in Italy may triple in 2020 as the government aims to lesser its reliance on imports, according to Marijuana Business Daily.
The only organization with the license to cultivate medical cannabis in Italy, Stabilimento Chimico Farmaceutico di Firenze (SCFF), was recently authorized by Italy's health ministry to produce 500 kilograms of cannabis flower in 2020, the publication said.
This year's production is reportedly expected to total less than 200 kilograms.
Last year, 578 kilograms of medical marijuana were sold to patients in Italy, and it is estimated the sum will be much bigger for 2019. This indicates that domestic production has not met the demand in the country.
Don’t miss out on the top cannabis stories of the day. Click here to sign up for our daily insider newsletter.
“Imports will continue to be needed because planned domestic production won’t be enough,” Giuseppe Libutti, an Italian business lawyer, told Marijuana Business Daily.
Most of the imported medical marijuana in Italy is from the Netherlands. Aurora Cannabis Inc ACB is the only Canadian company to supply medical cannabis in Italy.
SCFF and the Italian region of Tuscany joined together to work on the production of medical cannabis and to produce evidence of its efficacy and safety, Marijuana Business Daily reported.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.